Vlado Perkovic's Publications

Liao J, Kang A, Xia C et alii
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial
Journal articles
2022
Diabetes and Metabolism
Barraclough JY, Yu J, Figtree GA et alii
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial
Journal articles
2022
Diabetes
Waijer SW, Provenzano M, Mulder S et alii
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology
Journal articles
2022
Diabetes
Lv J, Wong MG, Hladunewich MA et alii
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
Journal articles
2022
JAMA
Neuen BL, Oshima M, Agarwal R et alii
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
Journal articles
2022
Circulation
Perkovic V, Baeres F, Bakris G et alii
FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease
Journal articles
2022
Nephrology Dialysis Transplantation
Singh AK, Blackorby A, Cizman B et alii
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial
Journal articles
2022
Nephrology
Yu J, Li J, Leaver PJ et alii
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial
Journal articles
2022
Cardiovascular research
Shaman AM, Bain SC, Bakris GL et alii
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
Journal articles
2022
Circulation
Waijer SW, Sen T, Arnott C et alii
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease
Journal articles
2022
Clinical journal of the American Society of Nephrology : CJASN
Heerspink HJL, Oshima M, Zhang H et alii
Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial
Journal articles
2022
American Journal of Kidney Diseases
Liyanage T, Toyama T, Hockham C et alii
Prevalence of chronic kidney disease in Asia: A systematic review and analysis
Journal articles
2022
BMJ Global Health
Singh AK, Cizman B, Carroll K et alii
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial
Journal articles
2022
JAMA Internal Medicine
See EJ, Bello AK, Levin A et alii
Availability, coverage, and scope of health information systems for kidney care across world countries and regions
Journal articles
2022
Nephrology Dialysis Transplantation
Smeijer JD, Koomen J, Kohan DE et alii
Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure
Journal articles
2022
JACC: Heart Failure
Feng Y, Li Q, Finfer S et alii
A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation.
Journal articles
2022
Front Cardiovasc Med
Barratt J, Rovin B, Zhang H et alii
POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS
Journal articles
2022
Kidney International Reports
Feng Y, Li Q, Finfer S et alii
POS-019 A NOVEL RISK PREDICTION MODEL FOR SERVE ACUTE KIDNEY INJURY IN INTENSIVE CARE UNIT PATIENTS RECEIVING FLUID RESUSCITATION
Journal articles
2022
Kidney International Reports
Neuen BL, Oshima M, Perkovic V et alii
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial
Journal articles
2021
European Heart Journal
Singh AK, Carroll K, McMurray JJV et alii
Daprodustat for the treatment of anemia in patients not undergoing dialysis
Journal articles
2021
New England Journal of Medicine
Singh AK, Carroll K, Perkovic V et alii
Daprodustat for the treatment of anemia in patients undergoing dialysis
Journal articles
2021
New England Journal of Medicine
Sen T, Li J, Neuen BL et alii
Association between circulating gdf-15 and cardio-renal outcomes and effect of canagliflozin: Results from the canvas trial
Journal articles
2021
Journal of the American Heart Association
Perkovic V, Blackorby A, Cizman B et alii
The ASCEND-ND trial: study design and participant characteristics
Journal articles
2021
NEPHROLOGY DIALYSIS TRANSPLANTATION
Waijer SW, Gansevoort RT, Bakris GL et alii
The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial.
Journal articles
2021
Clin J Am Soc Nephrol
Wong MG, Lv J, Hladunewich MA et alii
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics
Journal articles
2021
American Journal of Nephrology
Feng KY, Li JW, Ianus J et alii
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis
Journal articles
2021
Diabetes

Vlado Perkovic's Publications

The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial

Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial

Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology

Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials

FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial

Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease

Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

Prevalence of chronic kidney disease in Asia: A systematic review and analysis

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial

Availability, coverage, and scope of health information systems for kidney care across world countries and regions

Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure

A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation.

POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS

POS-019 A NOVEL RISK PREDICTION MODEL FOR SERVE ACUTE KIDNEY INJURY IN INTENSIVE CARE UNIT PATIENTS RECEIVING FLUID RESUSCITATION

Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial

Daprodustat for the treatment of anemia in patients not undergoing dialysis

Daprodustat for the treatment of anemia in patients undergoing dialysis

Association between circulating gdf-15 and cardio-renal outcomes and effect of canagliflozin: Results from the canvas trial

The ASCEND-ND trial: study design and participant characteristics

The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial.

The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics

Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country